Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)
Public ClinicalTrials.gov record NCT02952820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder (SUNRISE 2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The key objectives of this study are to determine, using sleep diaries, whether lemborexant at the doses 5 milligrams (mg) and 10 mg is superior to placebo on subjective sleep onset, subjective sleep efficiency, and subjective sleep maintenance in participants with insomnia disorder.
Study identification
- NCT ID
- NCT02952820
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 971 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2016 (Actual)
- Primary completion
- Jan 8, 2019 (Actual)
- Completion
- Jan 8, 2019 (Actual)
- Last update posted
- Feb 6, 2020
2016 – 2019
United States locations
- U.S. sites
- 42
- U.S. states
- 19
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Facility # 1 | Chandler | Arizona | 85224 | — |
| Facility # 2 | Chandler | Arizona | 85224 | — |
| Facility # 1 | Rogers | Arkansas | 72758 | — |
| Facility # 1 | Beverly Hills | California | 90210 | — |
| Facility # 2 | Los Angeles | California | 90048 | — |
| Facility # 1 | Los Angeles | California | 90069 | — |
| Facility # 1 | Redlands | California | 92374 | — |
| Facility # 1 | Sacramento | California | 95821 | — |
| Facility # 1 | Santa Monica | California | 90404 | — |
| Facility # 1 | Torrance | California | 90502 | — |
| Facility # 1 | Colorado Springs | Colorado | 80909 | — |
| Facility # 1 | Celebration | Florida | 34747 | — |
| Facility # 1 | Hialeah | Florida | 33016 | — |
| Facility # 1 | Homestead | Florida | 33030 | — |
| Facility # 1 | Jacksonville | Florida | 32256 | — |
| Facility # 1 | Lauderhill | Florida | 33319 | — |
| Facility # 1 | Maitland | Florida | 32751 | — |
| Innovative Clinical Research Inc | Miami | Florida | 33161 | — |
| Facility # 1 | Ocala | Florida | 34471 | — |
| Facility # 1 | Orlando | Florida | 32801 | — |
| Facility # 1 | Oviedo | Florida | 32765 | — |
| Facility # 1 | Pinellas Park | Florida | 33781 | — |
| Facility # 1 | Tampa | Florida | 33634 | — |
| Facility # 1 | The Villages | Florida | 32162 | — |
| Facility # 1 | Evansville | Indiana | 47714 | — |
| Facility # 1 | Elkridge | Maryland | 21075 | — |
| Facility # 1 | Quincy | Massachusetts | 2169 | — |
| Facility # 1 | Kansas City | Missouri | 64114 | — |
| Facility # 1 | Albuquerque | New Mexico | 87109 | — |
| Facility # 1 | Brooklyn | New York | 11235 | — |
| Facility # 1 | Hickory | North Carolina | 28601 | — |
| Facility # 1 | Dayton | Ohio | 45417 | — |
| Facility # 2 | Oklahoma City | Oklahoma | 73103 | — |
| Facility # 1 | Oklahoma City | Oklahoma | 73112 | — |
| Facility # 1 | Portland | Oregon | 97210 | — |
| Facility # 1 | Lincoln | Rhode Island | 2865 | — |
| Facility # 1 | Memphis | Tennessee | 38119 | — |
| Facility # 1 | Austin | Texas | 78705 | — |
| Facility # 2 | Austin | Texas | 78731 | — |
| Facility # 1 | Fort Worth | Texas | 76135 | — |
| Facility # 1 | San Angelo | Texas | 76904 | — |
| Facility # 1 | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02952820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02952820 live on ClinicalTrials.gov.